MANUFACTURERS LIFE INSURANCE COMPANY, THE - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 149 filers reported holding REATA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,638,293
-11.7%
16,068
-21.3%
0.00%0.0%
Q1 2023$1,855,768
+349.0%
20,411
+87.6%
0.00%
Q4 2022$413,293
+47.6%
10,879
-2.4%
0.00%
Q3 2022$279,973
-17.9%
11,141
-0.7%
0.00%
Q2 2022$340,915
-9.0%
11,218
-1.9%
0.00%
Q1 2022$374,643
-0.1%
11,436
-19.6%
0.00%
Q4 2021$375,000
-73.7%
14,217
+0.3%
0.00%
-100.0%
Q3 2021$1,426,000
-35.0%
14,178
-8.5%
0.00%
-50.0%
Q2 2021$2,193,000
+5.1%
15,498
+7.2%
0.00%0.0%
Q1 2020$2,087,000
-20.5%
14,461
+12.6%
0.00%
-33.3%
Q4 2019$2,625,000
+145.1%
12,841
+1.0%
0.00%
+200.0%
Q3 2019$1,071,000
-11.1%
12,717
-0.4%
0.00%0.0%
Q2 2019$1,205,000
+12.0%
12,769
+1.4%
0.00%0.0%
Q1 2019$1,076,000
+67.9%
12,591
+10.1%
0.00%0.0%
Q4 2018$641,000
-36.9%
11,436
-7.9%
0.00%0.0%
Q3 2018$1,016,000
+135.7%
12,421
+0.7%
0.00%
Q2 2018$431,000
+130.5%
12,332
+35.1%
0.00%
Q1 2018$187,000
-30.7%
9,125
-4.3%
0.00%
Q4 2017$270,000
-4.3%
9,536
+5.3%
0.00%
Q3 2017$282,000
+21.0%
9,052
+23.3%
0.00%
Q2 2017$233,000
+184.1%
7,343
+102.4%
0.00%
Q1 2017$82,000
+115.8%
3,628
+106.5%
0.00%
Q4 2016$38,000
+171.4%
1,757
+220.0%
0.00%
Q3 2016$14,0005490.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders